COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 284: Articles 2831-2840  | Next

The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
Neil, M., McLachlan, S., Fenton, N.
10.1101/2024.03.09.24304015 — Posted: 2024-03-16
Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP
The OpenSAFELY Collaborative, , Andrews, C. D., Prestige, E., Parker, E. P. K., Walker, V., Palmer, T., Schaffer, A. L., Green, A. C., Curtis, H. J., Walker, A. J., Smith, R. M., Wood, C., Bates, C., Mehrkar, A., MacKenna, B., Bacon, S. C., Goldacre, B., Hernan, M. A., Sterne, J. A., Hulme, W. J.
10.1101/2024.03.15.24304277 — Posted: 2024-03-16
Frequency of Depressive Symptoms and Suicidal Ideation Among University Students Before and After the COVID-19 Pandemic
Macalli, M., Castel, L., Jacqmin-gadda, H., Tournier, M., Galera, C., Pereira, E., Tzourio, C.
10.1101/2024.03.14.24304160 — Posted: 2024-03-16
ONE HEALTH APPROACH ON SARS-COV-2 - USING SHEEP AS SENTINEL ANIMALS TO INCREASE FUTURE PANDEMIC PREPAREDNESS - a pilot study
Samojlovic, M., Mesquita, J., Santos-Silva, S., Neptin, M., Esbjornsson, J.
10.1101/2024.03.15.585163 — Posted: 2024-03-15
Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France
Lee, A., Davido, B., Beck, E., Demont, C., Joshi, K., Kohli, M., Maschio, M., Uhart, M., El Mouaddin, N.
10.1101/2024.03.13.24304170 — Posted: 2024-03-15
Incidence, risk factors, and clinical symptom profile of reinfection during Omicron-dominated COVID-19 outbreak in Hong Kong: A retrospective cohort study
Huang, Z., Luo, J., Li, H., Cheng, X., Tang, H. T., Wong, H. K., Cheung, C. H., Bian, Z., Lyu, A., Tian, L.
10.1101/2024.03.12.24303945 — Posted: 2024-03-15
Changes in lung function and dyspnea perception in Colombian Covid-19 patients after a 12-week pulmonary rehabilitation program.
Zona, D. C., Paez-Mora, C. D., Angarita-Sierra, T., Rojas-Paredes, M. E., Cano-Trejos, D.
10.1101/2024.03.11.24303896 — Posted: 2024-03-15
Quantifying Oxygen Demand by Patients Hospitalized with COVID-19 at a Large Safety-Net Hospital Using Multiple Methodologies
Vanderburg, S., Law, T., Shete, P. B., Riviello, E. D., Hendrickson, C. M., Burns, G. D., Jain, V., Lipnick, M. S.
10.1101/2024.03.13.24304251 — Posted: 2024-03-15
Clinical characterization of new-onset chronic musculoskeletal pain in Long COVID: a cross-sectional study
Khoja, O., Silva-Passadouro, B., Cristescu, E., McEwan, K., Doherty, D., OConnell, F., Ponchel, F., Mulvey, M., Astill, S., Tan, A. L., Sivan, M.
10.1101/2024.03.09.24304024 — Posted: 2024-03-15
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study
SANA, A., DJEMAI, E., DE VREYER, P., THIVILLON, T., BADOLO, H., BERTHE, A., KANIA, D.
10.1101/2024.03.13.24304208 — Posted: 2024-03-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).